Mary Agnes Carey has covered health reform and federal health policy for more than 15 years as an editor at CQ HealthBeat
, as Capitol Hill Bureau Chief for Congressional Quarterly
and at Dow Jones Newswires. A frequent radio and television commentator, recently featured on the Nightly Business Report, the PBS NewsHour and on NPR affiliates nationwide, Mary Agnes has a thorough understanding of both the policy and politics of health reform. She worked for newspapers in Connecticut and Pennsylvania, and has a master's degree in journalism from Columbia University. | Contact: MaryAgnesC@kff.org | @MaryAgnesCarey
Officials, responding to recent Supreme Court actions, are seeking to overcome employers’ religious objections to the birth control coverage mandate.
Dr. Robert Galvin, who helps executives at 50 companies purchase health care for employees, tells KHN that workers must become savvier consumers.
Tuesday's conflicting rulings could affect subsidies for millions of Americans.
As Congress and the VA look to ease long wait times by sending more patients to outside providers, Dr. Ken Kizer, a former VA undersecretary for health, discusses how such an effort could play out.
The court says closely held corporations may be exempted from the health law’s contraceptive mandate.
Critics argue that some facilities using the program should not be eligible and that the money they receive from the sale of the discounted drugs is not always being plowed back into patient care.
The cabinet member who shepherded the implementation of the health law told the president last month that she wanted to leave after open enrollment was finished, a White House official says.
The enrollment period for the policies for individuals and small groups offered through the health law will expire at the end of this month. Here’s some basic information for those of you waiting until the last minute to shop.
Republicans have refused in the past to fund the federal online marketplace so health officials are looking at other ways to get the money.
Officials say proposed alterations would help seniors and save money but some patient groups and the drug industry are raising concerns.